mibefradil has been researched along with Myocardial Ischemia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (68.42) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanc, T; Richard, V; Thuillez, C; Tron, C | 1 |
| Reimer, KA; Schwartz, LM; Vander Heide, RS | 1 |
| Braun, S; Emanuelsson, H; Kobrin, I; van der Wall, EE | 1 |
| Bühler, M; Clozel, JP; Roux, S | 1 |
| Billman, GE; Hamlin, RL | 1 |
| Alpert, JS; Bakx, AL; Braun, S; Frishman, WH; Kobrin, I; Schneeweiss, A; Tzivoni, D | 1 |
| Braat, S; Kadr, H; Kobrin, I; Ramires, JA; Rutsch, W; Tzivoni, D | 1 |
| Bieska, G; Charlon, V; Kobrin, I; Lindberg, E; Pordy, R | 1 |
| Hofmann, D; McCarthy, J; Muller, CA; Opie, LH; Peisach, M; Pineda, CA | 1 |
| Cleophas, TJ; Daniëls, MC; Hendriks, MG; Holwerda, NJ; Schelling, A; van der Vring, JA; Withagen, PJ | 1 |
| Behrends, M; Heusch, G; Schulz, R | 1 |
| Curtis, MJ; Farkas, A; Qureshi, A | 1 |
| Budihna, MV; Grasic Kuhar, C | 1 |
| Arh, M; Budihna, MV | 1 |
| Antman, EM; Marsh, JD | 1 |
| Botvin, S; Gilula, Z; Klutstein, MW; Kobrin, I; Reisin, L; Tzivoni, D | 1 |
| Thadani, U | 1 |
| Dean, DM; Gervais, PB; Goodman, S; Langer, A; Lee, DS; Lenis, J; Ma, P | 1 |
| Billman, GE | 1 |
1 review(s) available for mibefradil and Myocardial Ischemia
| Article | Year |
|---|---|
Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
Topics: Adolescent; Adult; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Safety; Tetrahydronaphthalenes | 1998 |
7 trial(s) available for mibefradil and Myocardial Ischemia
| Article | Year |
|---|---|
Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group.
Topics: Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Tetrahydronaphthalenes | 1996 |
Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Benzimidazoles; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Tetrahydronaphthalenes | 1997 |
Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
Topics: Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Double-Blind Method; Electrocardiography, Ambulatory; Exercise; Exercise Test; Female; Heart Rate; Hemodynamics; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Nitroglycerin; Prospective Studies; Tetrahydronaphthalenes; Vasodilator Agents | 1997 |
Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
Topics: Adolescent; Adult; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Safety; Tetrahydronaphthalenes | 1998 |
Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Resear
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Diltiazem; Dizziness; Double-Blind Method; Drug Combinations; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia; Physical Exertion; Tetrahydronaphthalenes; Time Factors | 1999 |
The effect of mibefradil on ischemic episodes with and without increase in heart rate.
Topics: Angina Pectoris; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia | 2000 |
Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial.
Topics: Angina Pectoris; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Diltiazem; Double-Blind Method; Female; Humans; Male; Mibefradil; Middle Aged; Myocardial Ischemia | 2002 |
12 other study(ies) available for mibefradil and Myocardial Ischemia
| Article | Year |
|---|---|
Infarct size-limiting properties of Ro 40-5967, a novel nondihydropyridine calcium channel, in anesthetized rats: comparison with verapamil.
Topics: Anesthesia; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Heart Rate; Hemodynamics; Male; Mibefradil; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Tetrahydronaphthalenes; Verapamil | 1995 |
The novel calcium antagonist Ro 40-5967 limits myocardial infarct size in the dog.
Topics: Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Dogs; Female; Heart; Heart Rate; Male; Mibefradil; Myocardial Infarction; Myocardial Ischemia; Myocardium; Tetrahydronaphthalenes; Verapamil | 1994 |
Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
Topics: Amlodipine; Angina Pectoris, Variant; Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Dogs; Heart Rate; Intra-Aortic Balloon Pumping; Mibefradil; Myocardial Ischemia; Tetrahydronaphthalenes | 1996 |
The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Heart Ventricles; Mibefradil; Myocardial Ischemia; Tetrahydronaphthalenes; Verapamil | 1996 |
Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electrocardiography; Heart Ventricles; Infusions, Intravenous; Male; Mibefradil; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Swine; Tetrahydronaphthalenes; Ventricular Fibrillation; Verapamil | 1998 |
Effects of verapamil and mibefradil on regional blood flow and function in normal and ischemic myocardium.
Topics: Benzimidazoles; Calcium Channel Blockers; Coronary Circulation; Heart Function Tests; Humans; Mibefradil; Myocardial Ischemia; Tetrahydronaphthalenes; Verapamil | 1999 |
Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Electrocardiography; Heart; Heart Ventricles; Hemodynamics; In Vitro Techniques; Male; Mibefradil; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Perfusion; Potassium; Random Allocation; Rats; Rats, Wistar; Ventricular Fibrillation; Verapamil | 1999 |
Effects of mibefradil and verapamil on ischemic-reperfusion in the hearts of guinea pigs with acute renal failure.
Topics: Acute Kidney Injury; Animals; Calcium Channel Blockers; Coronary Circulation; Female; Guinea Pigs; L-Lactate Dehydrogenase; Male; Mibefradil; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Verapamil | 2000 |
Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Circulation; Dihydropyridines; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Mibefradil; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitrendipine; Pressure; Rats; Rats, Wistar; Reference Values; Ventricular Function, Left | 2000 |
T-type calcium channel blockade in the management of chronic ischemic heart disease.
Topics: Calcium Channel Blockers; Calcium Channels; Chronic Disease; Drug Interactions; Heart Rate; Humans; Mibefradil; Myocardial Ischemia | 2000 |
Selective L-type, T-type, and nonspecific calcium-channel blockers for stable angina pectoris.
Topics: Angina Pectoris; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Diltiazem; Humans; Mibefradil; Myocardial Ischemia | 2002 |
Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
Topics: Animals; Benzimidazoles; Binding Sites; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Disease Susceptibility; Dogs; Dose-Response Relationship, Drug; Heart Rate; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Physical Exertion; Tetrahydronaphthalenes; Ventricular Fibrillation; Verapamil | 1992 |